Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is N/A as of Tuesday, October 6, 2026.
DEBT TO ASSETS RATIO
N/A
Eocene Ltd.
Market Cap
$3.54M
Debt to Assets Ratio
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| Eocene Ltd. (EOCN) | $3.54M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% |
| Nexalin Technology, Inc. (NXL)vs › | $3.60M | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.60M | 0.00% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.60M | 0.14% |
| Moolec Science S.A. (MLEC)vs › | $3.46M | 0.64% |
| Evogene Ltd. (EVGN)vs › | $3.68M | 0.16% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.72M | 0.06% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | 0.02% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.23M | 0.06% |
Debt/Assets
N/A
Debt/Equity
N/A
Current Ratio
N/A
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
